🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Tomás Pascual

Breast Cancer Research Foundation

ORCID: 0000-0001-8431-3183

Also affiliated with Hospital Clínic de Barcelona, Cancer Clinic, Solti, Fundació Clínic per a la Recerca Biomèdica, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile
2.4Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis

Nature Cancer(2022)10.1038/s43018-022-00491-x
Top 9%
2.4DataRank
Top 9%114 citations

Toshinori Hinoue, Gregory Wheeler, Benjamin Kelly, Ana C. Garrido-Castro, Tomás Pascual +53 more

Papers

Driven by 11 papers — median percentile 46. Top paper: “Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis”.

Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis

Nature Cancer(2022)10.1038/s43018-022-00491-x
Top 9%
2.4DataRank
Top 9%114 citations

Toshinori Hinoue, Gregory Wheeler, Benjamin Kelly, Ana C. Garrido-Castro, Tomás Pascual +53 more

Multiplatform Analysis of Primary and Metastatic Breast Tumors from the AURORA US Network identifies microenvironment and epigenetics drivers of metastasis

Research Square(2022)10.21203/rs.3.rs-1221704/v1
N/A
0.165DataRank · unranked
2 citations

Susana García‐Recio, Toshinori Hinoue4, Gregory Wheeler, Benjamin Kelly, Ana C. Garrido-Castro +49 more

Clinical Subtype, Treatment Response, and Survival in De Novo and Recurrent Metastatic Breast Cancer

Research Square(2022)10.21203/rs.3.rs-1479039/v1
N/A
0DataRank · unranked
0 citations

Tomás Pascual, Allison M. Deal, Amy Wheless, Charles M. Perou, E. Claire Dees +2 more

Prognostic value of HER2DX in early-stage HER2-positive breast cancer: a comprehensive analysis of 757 patients in the Sweden Cancerome Analysis Network—Breast dataset (SCAN-B)

ESMO Open(2024)10.1016/j.esmoop.2024.102388
N/A
0DataRank · unranked
18 citations

Tomás Pascual, Fara Brasó‐Maristany, Laia Paré, Olga Martínez‐Sáez, Javier Cortés +15 more

Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC)

Annals of Oncology(2024)10.1016/j.annonc.2024.12.010
N/A
0DataRank · unranked
3 citations

Maki Tanioka, Sung Gwe Ahn, Paola Zagami, Tomás Pascual, Mattia Rediti +18 more

Clinical subtype, treatment response, and survival in De Novo and recurrent metastatic breast cancer

UNC Libraries(2024)10.17615/nqjk-v350
N/A
0DataRank · unranked
0 citations

Danielle M. File, A.M. Deal, L. Carey, Elizabeth Claire Dees, Charles M. Perou +2 more

Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis

UNC Libraries(2024)10.17615/m9ck-zv98
N/A
0DataRank · unranked
0 citations

Jonathan C. Silverstein, AURORA US Network, Melina E Sanders, P.W. Laird, C.M. Perou +53 more

Figure S4 from A Prognostic Model Based on PAM50 and Clinical Variables (PAM50MET) for Metastatic Hormone Receptor–positive HER2-negative Breast Cancer

10.1158/1078-0432.22477253
N/A
0DataRank · unranked
0 citations

Yi-Hsuan Tsai, Tomás Pascual, Laia Paré, Barbara Adamo, María Vidal +8 more

A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation

The Lancet Oncology(2020)10.1016/s1470-2045(20)30450-2
N/A
0DataRank · unranked
75 citations

Valentina Guarneri, Laia Paré, Gaia Griguolo, Tomás Pascual, Maria Vittoria Dieci +34 more

Figure S1 from A Prognostic Model Based on PAM50 and Clinical Variables (PAM50MET) for Metastatic Hormone Receptor–positive HER2-negative Breast Cancer

10.1158/1078-0432.22477262
Top 100%
0DataRank
Top 100%0 citations

Yi-Hsuan Tsai, Tomás Pascual, Laia Paré, Barbara Adamo, María Vidal +8 more

Clinical subtype, treatment response, and survival in De Novo and recurrent metastatic breast cancer

Breast Cancer Research and Treatment(2022)10.1007/s10549-022-06700-6
N/A
0DataRank · unranked
26 citations

Tomás Pascual, Allison M. Deal, Amy Wheless, Charles M. Perou, Elizabeth Claire Dees +2 more